ARCHIVES

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

This article is from The Cancer Letter archive.

Vol. 06 No. 24 | June 13, 1980

Download PDF Visit The Full Archive

Related Articles

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Expiring Program Offer Flexibility

February 12, 1982